tiprankstipranks
Advertisement
Advertisement

PEPG Stock Latest News

PepGen Maintained at Buy as Analyst Cites Encouraging DM1 Safety/Efficacy Profile and Keeps $20 Price Target
RatingsPepGen Maintained at Buy as Analyst Cites Encouraging DM1 Safety/Efficacy Profile and Keeps $20 Price Target
16d ago
PEPG
PepGen Advances PGN-EDODM1 Trial and Strengthens Finances
PremiumCompany Announcements
PepGen Advances PGN-EDODM1 Trial and Strengthens Finances
17d ago
8K
PEPG
PepGen reports Q2 EPS (26c), consensus (29c)
PremiumThe Fly
PepGen reports Q2 EPS (26c), consensus (29c)
17d ago
PEPG
PepGen to advance PGN-EDODM1 into highest dose cohort
PremiumThe Fly
PepGen to advance PGN-EDODM1 into highest dose cohort
17d ago
PEPG
PepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
PremiumRatings
PepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
23d ago
PEPG
PepGen Shareholders Back Directors and KPMG at 2026 Meeting
PremiumCompany AnnouncementsPepGen Shareholders Back Directors and KPMG at 2026 Meeting
2M ago
8K
PEPG
Craig-Hallum bullish on PepGen, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on PepGen, initiates with a Buy
2M ago
PEPG
PepGen initiated with a Buy at Craig-Hallum
Premium
The Fly
PepGen initiated with a Buy at Craig-Hallum
2M ago
PEPG
PepGen Highlights DM1 Program Progress in Updated Presentation
PremiumCompany Announcements
PepGen Highlights DM1 Program Progress in Updated Presentation
3M ago
8K
PEPG
PepGen files $400M mixed securities shelf
PremiumThe Fly
PepGen files $400M mixed securities shelf
3M ago
PEPG
PepGen price target lowered to $4 from $5 at Wedbush
PremiumThe Fly
PepGen price target lowered to $4 from $5 at Wedbush
3M ago
PEPG
PepGen reports Q1 EPS (26c), consensus (31c)
PremiumThe Fly
PepGen reports Q1 EPS (26c), consensus (31c)
3M ago
PEPG
PepGen sees cash runway into 2H27
PremiumThe FlyPepGen sees cash runway into 2H27
3M ago
PEPG
Video: Deals in food and pharmaceuticals headline busy morning of M&A
Premium
The Fly
Video: Deals in food and pharmaceuticals headline busy morning of M&A
5M ago
UL
LLY
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
Premium
Ratings
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
5M ago
PEPG
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
PremiumRatings
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
5M ago
PEPG
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
PremiumCompany Announcements
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
5M ago
8K
PEPG
Closing Bell Movers: Phreesia down over 20% after guidance cut
PremiumThe Fly
Closing Bell Movers: Phreesia down over 20% after guidance cut
5M ago
CVV
PHR
PepGen down 46% at $2.30 after Phase 2 Freedom trial data
PremiumThe Fly
PepGen down 46% at $2.30 after Phase 2 Freedom trial data
5M ago
PEPG
PepGen Inc trading resumes
PremiumThe FlyPepGen Inc trading resumes
5M ago
PEPG
PepGen reports ‘promising’ topline results from MAD cohort
Premium
The Fly
PepGen reports ‘promising’ topline results from MAD cohort
5M ago
PEPG
PepGen Inc trading halted, news pending
Premium
The Fly
PepGen Inc trading halted, news pending
5M ago
PEPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >